Real-time enrollment status for this prader-willi syndrome clinical trial
Current Status
Suspended
Checked: June 1, 2026 at 11:31 PM UTC
| NCT Number | NCT07197034 |
| Recruiting Status | Suspended |
| Condition | Prader-Willi Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Aardvark Therapeutics, Inc. |
| Last Updated on CT.gov | March 19, 2026 (Mar 19, 2026) |
As of June 1, 2026: Clinical trial NCT07197034 is currently suspended participants. This clinical trial study for prader-willi syndrome is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Aardvark Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07197034 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07197034 was last updated Mar 19, 2026 (March 19, 2026). HelloStudys verifies this status automatically.